Research Keyword: flow cytometry

Fusarium spp. in Metalworking Fluid Systems: Companions Forever

Researchers analyzed over 48,000 metalworking fluid samples from machines worldwide over 10 years and found that fungal contamination is very common, especially on machine surfaces. While companies add chemicals called fungicides to prevent fungal growth, these chemicals have limited effectiveness and fungi often survive or adapt to them. As regulations increasingly restrict these fungicides, the manufacturing industry will need to find new ways to prevent fungal contamination by changing the chemical composition of metalworking fluids themselves.

Read More »

Galacto-Oligosaccharides Exert Bifidogenic Effects at Capsule-Compatible Ultra-Low Doses

This study tested whether tiny doses of a prebiotic called galacto-oligosaccharides (GOS) could be effective when taken in capsule form instead of large sachets. Researchers used a specially designed laboratory system to simulate how these compounds work in the human gut. Even at the lowest dose tested (0.5 g), the GOS successfully increased beneficial gut bacteria and produced helpful compounds that support digestive health, while producing minimal gas.

Read More »

Lentinan inhibits colorectal cancer stemness by binding CD133 and suppressing the CD133/p85/p-AKT signaling axis

Researchers discovered that lentinan, a natural compound from shiitake mushrooms, can specifically target and kill cancer stem cells in colorectal cancer by binding to a protein called CD133. This is significant because cancer stem cells are the reason why cancers come back even after treatment. By blocking a specific pathway these cells use to survive, lentinan may help prevent cancer recurrence and reduce the side effects associated with traditional chemotherapy.

Read More »

Classic psychedelics do not affect T cell and monocyte immune responses

Researchers tested whether common psychedelic drugs (LSD, psilocin, DMT, and mescaline) directly affect human immune cells in laboratory conditions. They found that these psychedelics did not suppress T cell function or immune signaling at the doses tested. This is good news for patients with serious illnesses who might benefit from psychedelic-assisted therapy, as it suggests these treatments won’t dangerously weaken their already compromised immune systems.

Read More »

Evaluation of Anticancer Potential of Ganoderma lucidum on MCF-7 Breast Cancer Cells Through Genetic Transcription of Energy Metabolism

Researchers tested extracts from Ganoderma lucidum (Reishi mushroom) against breast cancer cells in the laboratory. They found that the methanol extract was particularly effective at killing cancer cells while leaving healthy cells relatively unharmed. The mushroom works by disrupting the cancer cells’ metabolism and triggering programmed cell death, making it a promising natural treatment option that could complement conventional cancer therapies.

Read More »

In vitro antitumor effects of methanolic extracts of three Ganoderma mushrooms

Researchers tested extracts from three types of medicinal mushrooms (Ganoderma) against cancer cells in laboratory tests. They found that one species was particularly effective against liver cancer cells, while two other species worked well against breast cancer cells. The extracts killed cancer cells while being much less harmful to normal cells, suggesting they could potentially be developed into new cancer treatments.

Read More »

Synergistic potential and apoptosis induction of Bunium persicum essential oil and its pure components, cuminaldehyde and γ-terpinene, in combination with fluconazole on Candida albicans isolates: in vitro and in silico evaluation

Researchers studied how Bunium persicum essential oil and two of its active components work together with the antifungal drug fluconazole to fight resistant Candida yeast infections. They found that cuminaldehyde, one of the oil’s main components, was particularly effective when combined with fluconazole and could trigger yeast cell death. These natural compounds could offer a promising new approach to treating fungal infections that have become resistant to standard medications.

Read More »

Honeybee associated Aspergillus niger AW17 as a source of selective anticancer compounds with cytotoxicity evaluation in human cancer cell lines

Scientists discovered that a fungus found in honeybees can produce compounds that effectively kill cancer cells while leaving healthy cells largely unharmed. The fungus (Aspergillus niger AW17) contains unique bioactive compounds including high levels of oleic acid and a rare compound called pachymic acid. When tested against four types of human cancer cells, the fungal extract was particularly effective against liver and colorectal cancer. This finding suggests that exploring specialized environments like beehives could lead to new cancer treatments with fewer side effects.

Read More »

Disseminated mucormycosis leading to a fatal gastrointestinal perforation in a pediatric case of EBV-associated Hemophagocytic lymphohistiocytosis

A 12-month-old girl with a serious immune system disorder called HLH developed a rare and dangerous fungal infection called mucormycosis. Despite receiving the best available treatments, the fungal infection spread throughout her digestive system and caused a perforation (hole) in her intestines. The doctors found it difficult to diagnose the fungal infection early because the warning signs were subtle, and the infection progressed very rapidly. Unfortunately, the girl passed away despite emergency surgery and high-dose antifungal medications.

Read More »

Loss of the Aspergillus fumigatus spindle assembly checkpoint components, SldA or SldB, generates triazole heteroresistant conidial populations

This research reveals that disabling certain cell division checkpoint proteins in the fungus Aspergillus fumigatus creates populations resistant to triazole antifungal drugs. The resistant fungal cells appear to have abnormal amounts of genetic material, suggesting that loss of these checkpoint controls allows cells with extra chromosomes to survive drug exposure. This discovery provides new insight into how dangerous fungal infections can develop resistance to our most important antifungal treatments.

Read More »
Scroll to Top